Search Results - "Suzich, Joann"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Differential expression and roles of Staphylococcus aureus virulence determinants during colonization and disease by Jenkins, Amy, Diep, Binh An, Mai, Thuy T, Vo, Nhung H, Warrener, Paul, Suzich, Joann, Stover, C Kendall, Sellman, Bret R

    Published in mBio (17-02-2015)
    “…Staphylococcus aureus is a Gram-positive, commensal bacterium known to asymptomatically colonize the human skin, nares, and gastrointestinal tract. Colonized…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Attenuate Newcastle disease virus by codon modification of the glycoproteins and phosphoprotein genes by Wang, Weijia, Cheng, Xing, Buske, Paul J., Suzich, JoAnn A., Jin, Hong

    Published in Virology (New York, N.Y.) (01-02-2019)
    “…A codon modification strategy was used to attenuate the avian pathogenicity of an oncolytic mesogenic Newcastle disease virus (NDV) by targeting the three…”
    Get full text
    Journal Article
  8. 8

    A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head by Benjamin, Ebony, Wang, Weijia, McAuliffe, Josephine M, Palmer-Hill, Frances J, Kallewaard, Nicole L, Chen, Zhongying, Suzich, JoAnn A, Blair, Wade S, Jin, Hong, Zhu, Qing

    Published in Journal of virology (01-06-2014)
    “…Most neutralizing antibodies elicited during influenza virus infection or vaccination target immunodominant, variable epitopes on the globular head region of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Infection and Propagation of Human Rhinovirus C in Human Airway Epithelial Cells by WEIDONG HAO, BERNARD, Katie, BLAIR, Wade, QING ZHU, PATEL, Nita, ULBRANDT, Nancy, HUI FENG, SVABEK, Catherine, WILSON, Susan, STRACENER, Christina, WANG, Kathy, SUZICH, Joann

    Published in Journal of Virology (01-12-2012)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model by Tkaczyk, Christine, Hamilton, Melissa M, Datta, Vivekananda, Yang, Xiang Ping, Hilliard, Jamese J, Stephens, Geoffrey L, Sadowska, Agnieszka, Hua, Lei, O'Day, Terrence, Suzich, JoAnn, Stover, Charles Kendall, Sellman, Bret R

    Published in PloS one (02-10-2013)
    “…An optimal host response against Staphylococcus aureus skin and soft tissue infections (SSTI) is dependent on IL-1β and IL-17 mediated abscess formation. Alpha…”
    Get full text
    Journal Article
  12. 12

    Natural Polymorphisms and Resistance-Associated Mutations in the Fusion Protein of Respiratory Syncytial Virus (RSV): Effects on RSV Susceptibility to Palivizumab by Zhu, Qing, Patel, Nita K., McAuliffe, Josephine M., Zhu, Wei, Wachter, Leslie, McCarthy, Michael P., Suzich, JoAnn A.

    Published in The Journal of infectious diseases (15-02-2012)
    “…Specific mutations in respiratory syncytial virus (RSV) fusion protein can cause palivizumab resistance. We assessed the incidence of sequence polymorphisms…”
    Get full text
    Journal Article
  13. 13

    HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection by Ferrando-Martinez, Sara, Huang, Kelly, Bennett, Angie Snell, Sterba, Patricia, Yu, Li, Suzich, JoAnn A, Janssen, Harry L A, Robbins, Scott H

    Published in JHEP reports (01-09-2019)
    “…Current therapies for chronic hepatitis B virus (HBV) infection control viral replication but do not eliminate the risk of progression to hepatocellular…”
    Get full text
    Journal Article
  14. 14
  15. 15

    POTENTIAL FOR PALIVIZUMAB INTERFERENCE WITH COMMERCIALLY AVAILABLE ANTIBODY-ANTIGEN BASED RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTIC ASSAYS by DEMING, Damon J, PATEL, Nita, MCCARTHY, Michael P, MISHRA, Lalji, SHAPIRO, Alan M, SUZICH, Joann A

    Published in The Pediatric infectious disease journal (01-10-2013)
    “…Palivizumab is a monoclonal antibody indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus infection in…”
    Get full text
    Journal Article
  16. 16

    A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult Volunteers by Evans, Thomas G., Bonnez, William, Rose, Robert C., Koenig, Scott, Demeter, Lisa, Suzich, JoAnn A., O’Brien, Diane, Campbell, Meredith, White, Wendy I., Balsley, James, Reichman, Richard C.

    Published in The Journal of infectious diseases (15-05-2001)
    “…Viruslike particles (VLPs) produced from the L1 protein of several papillomaviruses have induced protection from infection after live challenge in animal…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs by Sow, Fatoumata B, Gallup, Jack M, Krishnan, Subramaniam, Patera, Andriani C, Suzich, Joann, Ackermann, Mark R

    Published in Respiratory research (09-08-2011)
    “…Factors explaining the greater susceptibility of preterm infants to severe lower respiratory infections with respiratory syncytial virus (RSV) remain poorly…”
    Get full text
    Journal Article
  20. 20